Intuitive Surgical, Inc.
ISRGHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Intuitive Surgical, Inc. focuses on Medical Instruments & Supplies services and products. Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. With a market capitalization of $122.33B, it sits in large-cap territory. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.
Market Cap
$122.33B
Beta
—
P/E (TTM)
39.57
P/E (Fwd)
28.83
EPS (TTM)
$8.73
EPS (Fwd)
$11.98
ROE
17.4%
ROA
10.5%
Cash
$8.63B
Total Debt
$0
Free CF
—
52W Change
-33.4%
Annual Financials
Cash vs Debt
Intuitive Surgical, Inc. reports $8.63B in cash and $0 in total debt. Return on equity stands at 17.4%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 10.5% further supports the picture of efficient asset utilization. Revenue has grown from $6.22B (2022) to $10.06B (2025), reflecting a 62% increase over the period.
As with any equity investment, ISRG carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. No single metric tells the full story. Reviewing ISRG's risk profile alongside its fundamentals and technical indicators provides a more complete picture.